News Mundipharma buys rights to CellAct cancer drug Drug will be progressed through phase 3 trials in biliary tract cancer.
News US measles elimination status at risk as cases soar Measles cases are roaring back in the US, with nearly 1,300 cases so far this year, 25 years after the disease was declared eliminated by the CDC.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
